Page last updated: 2024-08-24

brequinar and carboplatin

brequinar has been researched along with carboplatin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
DeBerardinis, RJ; Fan, C; Glodowski, CR; Kaushik, A; Liao, C; Liu, J; Locasale, JW; McBrayer, SK; Mott, KR; Perou, CM; Vu, H; Zhang, Q	1

Other Studies

1 other study(ies) available for brequinar and carboplatin

Article	Year
Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers. Cancer research, 2022, 02-15, Volume: 82, Issue:4 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Carboplatin; Cell Line, Tumor; Cell Proliferation; Gene Expression Profiling; Humans; Metabolomics; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Molecular Targeted Therapy; Paclitaxel; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2022

Article

Year

Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers.

Cancer research, 2022, 02-15, Volume: 82, Issue:4

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Carboplatin; Cell Line, Tumor; Cell Proliferation; Gene Expression Profiling; Humans; Metabolomics; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Molecular Targeted Therapy; Paclitaxel; Signal Transduction; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2022